{"id": "article-24799_0", "title": "McCune-Albright Syndrome -- Continuing Education Activity", "content": "McCune-Albright syndrome is a rare genetic disordered originally recognized by the triad of polyostotic fibrous dysplasia, precocious puberty, and cafe-au-late spots. A variety of endocrine disorders, including hyperthyroidism, acromegaly, phosphate wasting, and Cushing syndrome are now considered as part of the endocrinopathies seen in this disorder. The variable constellation of symptoms arises from a somatic activating mutation of the GNAS gene, which is present in many tissue types. This activity reviews the etiology, presentation, evaluation, and management of McCune-Albright syndrome and reviews the role of the interprofessional team in evaluating, diagnosing, and managing the condition.", "contents": "McCune-Albright Syndrome -- Continuing Education Activity. McCune-Albright syndrome is a rare genetic disordered originally recognized by the triad of polyostotic fibrous dysplasia, precocious puberty, and cafe-au-late spots. A variety of endocrine disorders, including hyperthyroidism, acromegaly, phosphate wasting, and Cushing syndrome are now considered as part of the endocrinopathies seen in this disorder. The variable constellation of symptoms arises from a somatic activating mutation of the GNAS gene, which is present in many tissue types. This activity reviews the etiology, presentation, evaluation, and management of McCune-Albright syndrome and reviews the role of the interprofessional team in evaluating, diagnosing, and managing the condition."}
{"id": "article-24799_1", "title": "McCune-Albright Syndrome -- Continuing Education Activity", "content": "Objectives: Describe the pathophysiology of McCune-Albright syndrome. Explain the examination and evaluation strategies necessary to diagnose McCune-Albright syndrome. Summarize the treatment and management options available for McCune-Albright syndrome Review the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by McCune-Albright syndrome Access free multiple choice questions on this topic.", "contents": "McCune-Albright Syndrome -- Continuing Education Activity. Objectives: Describe the pathophysiology of McCune-Albright syndrome. Explain the examination and evaluation strategies necessary to diagnose McCune-Albright syndrome. Summarize the treatment and management options available for McCune-Albright syndrome Review the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by McCune-Albright syndrome Access free multiple choice questions on this topic."}
{"id": "article-24799_2", "title": "McCune-Albright Syndrome -- Introduction", "content": "McCune-Albright syndrome is a rare genetic disordered originally recognized by the triad of polyostotic fibrous dysplasia, precocious puberty, and caf\u00e9-au-lait spots. A\u00a0variety of endocrine disorders, including hyperthyroidism, acromegaly, phosphate wasting, and Cushing syndrome are now considered as part of the endocrinopathies seen in this disorder. The variable constellation of symptoms arises from a somatic activating mutation of the GNAS gene, which is present in many tissue types. [1]", "contents": "McCune-Albright Syndrome -- Introduction. McCune-Albright syndrome is a rare genetic disordered originally recognized by the triad of polyostotic fibrous dysplasia, precocious puberty, and caf\u00e9-au-lait spots. A\u00a0variety of endocrine disorders, including hyperthyroidism, acromegaly, phosphate wasting, and Cushing syndrome are now considered as part of the endocrinopathies seen in this disorder. The variable constellation of symptoms arises from a somatic activating mutation of the GNAS gene, which is present in many tissue types. [1]"}
{"id": "article-24799_3", "title": "McCune-Albright Syndrome -- Etiology", "content": "The cause of McCune-Albright syndrome is a spontaneous post zygotic missense mutation at ARG201 or Gln227 of the GNAS gene during embryogenesis. GNAS encodes the alpha subunit\u00a0portion of a G-signaling complex that\u00a0found in multiple tissue types, including bone, skin, and endocrine tissues.\u00a0\u00a0The mutation is distributed in a mosaic pattern and presenting signs and symptoms are dependent\u00a0on the time frame the mutation occurs.\u00a0 Mutated GNAS results in a constitutively active alpha subunit,\u00a0causing increased intracellular cAMP, and mediating the action of downstream hormones. [2]", "contents": "McCune-Albright Syndrome -- Etiology. The cause of McCune-Albright syndrome is a spontaneous post zygotic missense mutation at ARG201 or Gln227 of the GNAS gene during embryogenesis. GNAS encodes the alpha subunit\u00a0portion of a G-signaling complex that\u00a0found in multiple tissue types, including bone, skin, and endocrine tissues.\u00a0\u00a0The mutation is distributed in a mosaic pattern and presenting signs and symptoms are dependent\u00a0on the time frame the mutation occurs.\u00a0 Mutated GNAS results in a constitutively active alpha subunit,\u00a0causing increased intracellular cAMP, and mediating the action of downstream hormones. [2]"}
{"id": "article-24799_4", "title": "McCune-Albright Syndrome -- Epidemiology", "content": "The prevalence of McCune-Albright syndrome is estimated to be between 1 in 100,000 to 1 in 1,000,000. [1]", "contents": "McCune-Albright Syndrome -- Epidemiology. The prevalence of McCune-Albright syndrome is estimated to be between 1 in 100,000 to 1 in 1,000,000. [1]"}
{"id": "article-24799_5", "title": "McCune-Albright Syndrome -- Pathophysiology", "content": "An increase in intracellular cAMP signaling is responsible for the clinical manifestations of McCune-Albright syndrome. The phenotype is dependent on which tissue types the mutation occurs. [2] In bone, increased cAMP causes osteoblasts\u00a0to differentiate into stromal cells while inhibiting further differentiation, resulting in fibrous dysplasia. These fibrous dysplastic lesions then exhibit increased secretion of phosphaturic hormone fibroblastic growth factor-23 (FGF23),\u00a0causing\u00a0renal phosphate wasting. [3] Increased cAMP signaling in the skin results in stimulation of melanin production via alpha-MSH, resulting in caf\u00e9-au-lait macules. Increased cAMP in endocrine tissue\u00a0results in increased production and secretion of a specific hormone product.\u00a0 Affected\u00a0endocrine tissues can include the gonads, thyroid, pituitary, parathyroid, and adrenal glands. [1]", "contents": "McCune-Albright Syndrome -- Pathophysiology. An increase in intracellular cAMP signaling is responsible for the clinical manifestations of McCune-Albright syndrome. The phenotype is dependent on which tissue types the mutation occurs. [2] In bone, increased cAMP causes osteoblasts\u00a0to differentiate into stromal cells while inhibiting further differentiation, resulting in fibrous dysplasia. These fibrous dysplastic lesions then exhibit increased secretion of phosphaturic hormone fibroblastic growth factor-23 (FGF23),\u00a0causing\u00a0renal phosphate wasting. [3] Increased cAMP signaling in the skin results in stimulation of melanin production via alpha-MSH, resulting in caf\u00e9-au-lait macules. Increased cAMP in endocrine tissue\u00a0results in increased production and secretion of a specific hormone product.\u00a0 Affected\u00a0endocrine tissues can include the gonads, thyroid, pituitary, parathyroid, and adrenal glands. [1]"}
{"id": "article-24799_6", "title": "McCune-Albright Syndrome -- Histopathology", "content": "Characteristics of fibrous dysplasia include an increased number of thin and irregular trabeculae.\u00a0The marrow spaces get replaced by fibroblastic tissue.\u00a0 Lesions may be monostotic (involving one bone) or polyostotic (multiple bones involved). Commonly identified by radiograph, fibrodysplasia\u00a0shows a hazy, radiolucent, ground-glass pattern due to defective mineralization. [3]", "contents": "McCune-Albright Syndrome -- Histopathology. Characteristics of fibrous dysplasia include an increased number of thin and irregular trabeculae.\u00a0The marrow spaces get replaced by fibroblastic tissue.\u00a0 Lesions may be monostotic (involving one bone) or polyostotic (multiple bones involved). Commonly identified by radiograph, fibrodysplasia\u00a0shows a hazy, radiolucent, ground-glass pattern due to defective mineralization. [3]"}
{"id": "article-24799_7", "title": "McCune-Albright Syndrome -- History and Physical", "content": "Initial clinical presentation is typically due to either precocious puberty or symptoms related to fibrous dysplasia.\u00a0 Females can present with vaginal bleeding and development of breast tissue. Males can present with testicular enlargement, appearance pubic and axillary hair, and increased body odor. Caf\u00e9-au-lait spots may be appreciated in retrospect unless they are prominent.\u00a0 These spots are typically midline and described as having \u201ccoast of Maine\u201d jagged borders. [1]", "contents": "McCune-Albright Syndrome -- History and Physical. Initial clinical presentation is typically due to either precocious puberty or symptoms related to fibrous dysplasia.\u00a0 Females can present with vaginal bleeding and development of breast tissue. Males can present with testicular enlargement, appearance pubic and axillary hair, and increased body odor. Caf\u00e9-au-lait spots may be appreciated in retrospect unless they are prominent.\u00a0 These spots are typically midline and described as having \u201ccoast of Maine\u201d jagged borders. [1]"}
{"id": "article-24799_8", "title": "McCune-Albright Syndrome -- History and Physical", "content": "Fibrous dysplastic lesions\u00a0can present\u00a0as a pathologic fracture or pain.\u00a0 Lesions of the calvarium and facial bones are common and can present as painless facial asymmetry. Radiographs reveal a characteristic lesion of thinning cortex and intramedullary \u201cground glass.\u201d [4]", "contents": "McCune-Albright Syndrome -- History and Physical. Fibrous dysplastic lesions\u00a0can present\u00a0as a pathologic fracture or pain.\u00a0 Lesions of the calvarium and facial bones are common and can present as painless facial asymmetry. Radiographs reveal a characteristic lesion of thinning cortex and intramedullary \u201cground glass.\u201d [4]"}
{"id": "article-24799_9", "title": "McCune-Albright Syndrome -- History and Physical", "content": "Symptoms of endocrinopathies are specific to the\u00a0affected organ. Hyperthyroidism is common. Growth hormone and prolactin secretion present as acromegaly and disruption of normal gonadal function. Cushing syndrome is typically adrenal,\u00a0presents in the neonatal period and is most commonly transient. [1]", "contents": "McCune-Albright Syndrome -- History and Physical. Symptoms of endocrinopathies are specific to the\u00a0affected organ. Hyperthyroidism is common. Growth hormone and prolactin secretion present as acromegaly and disruption of normal gonadal function. Cushing syndrome is typically adrenal,\u00a0presents in the neonatal period and is most commonly transient. [1]"}
{"id": "article-24799_10", "title": "McCune-Albright Syndrome -- Evaluation", "content": "McCune-Albright syndrome is largely a clinical diagnosis. Genetic testing for GNAS mutation is commercially available, however, due to the mosaicism, false negatives do\u00a0occur, and a positive result contributes little to the clinical management. [2]", "contents": "McCune-Albright Syndrome -- Evaluation. McCune-Albright syndrome is largely a clinical diagnosis. Genetic testing for GNAS mutation is commercially available, however, due to the mosaicism, false negatives do\u00a0occur, and a positive result contributes little to the clinical management. [2]"}
{"id": "article-24799_11", "title": "McCune-Albright Syndrome -- Evaluation", "content": "Evaluation includes radiographs or computed tomography (CT) to identify and characterize fibrodysplastic lesions. In early childhood, patients with McCune-Albright syndrome are more likely to experience stress fractures that may lead to permanent deformity\u00a0if not stabilized. CT scan of the skull helps in the\u00a0diagnosis of craniofacial bone lesions and pituitary lesions. Regular vision and hearing tests can monitor lesions affecting those systems. \u00a0Baseline bone scan with 99Tc-methyl diphosphate\u00a0is\u00a0indicated in endocrinopathies that affect bone development. [5]", "contents": "McCune-Albright Syndrome -- Evaluation. Evaluation includes radiographs or computed tomography (CT) to identify and characterize fibrodysplastic lesions. In early childhood, patients with McCune-Albright syndrome are more likely to experience stress fractures that may lead to permanent deformity\u00a0if not stabilized. CT scan of the skull helps in the\u00a0diagnosis of craniofacial bone lesions and pituitary lesions. Regular vision and hearing tests can monitor lesions affecting those systems. \u00a0Baseline bone scan with 99Tc-methyl diphosphate\u00a0is\u00a0indicated in endocrinopathies that affect bone development. [5]"}
{"id": "article-24799_12", "title": "McCune-Albright Syndrome -- Evaluation", "content": "Precocious puberty in McCune-Albright syndrome is typically peripheral and due to activation of ovarian or testicular tissue. Evaluation includes serum estradiol and testosterone levels. Boys should have a testicular ultrasound to assess for hormonally active tumors.\u00a0 High levels of estradiol in girls may cause activation of hypothalamic-pituitary-gonadal axis, triggering\u00a0evaluation for central precocious puberty. Additionally, GnRH stimulation testing and serum measurements of luteinizing hormone and follicle-stimulating hormone may be warranted. [6]", "contents": "McCune-Albright Syndrome -- Evaluation. Precocious puberty in McCune-Albright syndrome is typically peripheral and due to activation of ovarian or testicular tissue. Evaluation includes serum estradiol and testosterone levels. Boys should have a testicular ultrasound to assess for hormonally active tumors.\u00a0 High levels of estradiol in girls may cause activation of hypothalamic-pituitary-gonadal axis, triggering\u00a0evaluation for central precocious puberty. Additionally, GnRH stimulation testing and serum measurements of luteinizing hormone and follicle-stimulating hormone may be warranted. [6]"}
{"id": "article-24799_13", "title": "McCune-Albright Syndrome -- Evaluation", "content": "Evaluation for growth hormone excess includes oral glucose tolerance test and serum growth hormone and prolactin measurements.\u00a0 Evaluation of hyperthyroidism includes measurement of thyroid-stimulating hormone (TSH), free and bound thyroxine, and T3. Periodic ultrasound is recommended with an appropriate follow-up of any abnormal findings. Monitoring levels\u00a0of serum phosphate and\u00a0renal\u00a0reabsorption of phosphate is also a recommendation. [7] [8]", "contents": "McCune-Albright Syndrome -- Evaluation. Evaluation for growth hormone excess includes oral glucose tolerance test and serum growth hormone and prolactin measurements.\u00a0 Evaluation of hyperthyroidism includes measurement of thyroid-stimulating hormone (TSH), free and bound thyroxine, and T3. Periodic ultrasound is recommended with an appropriate follow-up of any abnormal findings. Monitoring levels\u00a0of serum phosphate and\u00a0renal\u00a0reabsorption of phosphate is also a recommendation. [7] [8]"}
{"id": "article-24799_14", "title": "McCune-Albright Syndrome -- Treatment / Management", "content": "The mainstay treatment of gonadotropin-independent precocious puberty is aromatase inhibitors and more recently tamoxifen in females. In the case of the development of central precocious puberty, steady-state gonadotropin-releasing hormone analogs are used to downregulate hypothalamic-pituitary-gonadal axis. [9] [10] [11]", "contents": "McCune-Albright Syndrome -- Treatment / Management. The mainstay treatment of gonadotropin-independent precocious puberty is aromatase inhibitors and more recently tamoxifen in females. In the case of the development of central precocious puberty, steady-state gonadotropin-releasing hormone analogs are used to downregulate hypothalamic-pituitary-gonadal axis. [9] [10] [11]"}
{"id": "article-24799_15", "title": "McCune-Albright Syndrome -- Treatment / Management", "content": "Treatment of hyperthyroidism is initially managed medically with antithyroid medications and radioablation. \u00a0Growth hormone excess treatment is by somatostatin or direct GH receptor antagonists. Hyperprolactinemia management is with bromocriptine.\u00a0 In patients with demonstrated pituitary adenomas, surgical resection of the adenoma is an option.\u00a0 Treatment of hypophosphatemia with oral supplementation\u00a0is under debate, but supplementation should be used in the setting of rickets. [7] [8]", "contents": "McCune-Albright Syndrome -- Treatment / Management. Treatment of hyperthyroidism is initially managed medically with antithyroid medications and radioablation. \u00a0Growth hormone excess treatment is by somatostatin or direct GH receptor antagonists. Hyperprolactinemia management is with bromocriptine.\u00a0 In patients with demonstrated pituitary adenomas, surgical resection of the adenoma is an option.\u00a0 Treatment of hypophosphatemia with oral supplementation\u00a0is under debate, but supplementation should be used in the setting of rickets. [7] [8]"}
{"id": "article-24799_16", "title": "McCune-Albright Syndrome -- Treatment / Management", "content": "No definitive guidelines for surgical intervention of fibrous dysplastic lesions exist. However, common indications for surgical stabilization include progression of pain, stress fracture, deformity, or loss of function. The data for prophylactic surgery are lacking. Studies investigating the use of high dose bisphosphonates show mixed results, and currently,\u00a0the only indication for bisphosphonate therapy is pain relief. Surgical intervention\u00a0due to\u00a0cranial-facial lesions may be necessary when there is a potential for loss or sight or hearing.", "contents": "McCune-Albright Syndrome -- Treatment / Management. No definitive guidelines for surgical intervention of fibrous dysplastic lesions exist. However, common indications for surgical stabilization include progression of pain, stress fracture, deformity, or loss of function. The data for prophylactic surgery are lacking. Studies investigating the use of high dose bisphosphonates show mixed results, and currently,\u00a0the only indication for bisphosphonate therapy is pain relief. Surgical intervention\u00a0due to\u00a0cranial-facial lesions may be necessary when there is a potential for loss or sight or hearing."}
{"id": "article-24799_17", "title": "McCune-Albright Syndrome -- Differential Diagnosis", "content": "Neurofibromatosis and McCune-Albright syndrome both can present with\u00a0caf\u00e9-au-lait macules. The caf\u00e9-au-lait macules of neurofibromatosis typically have smooth borders,\u00a0 while the macules of McCune-Albright are midline and have\u00a0a jagged\u00a0or irregular appearance.\u00a0 Additionally, neurofibromatosis characteristically presents with neurofibromas, which are lacking in McCune-Albright syndrome. [1]", "contents": "McCune-Albright Syndrome -- Differential Diagnosis. Neurofibromatosis and McCune-Albright syndrome both can present with\u00a0caf\u00e9-au-lait macules. The caf\u00e9-au-lait macules of neurofibromatosis typically have smooth borders,\u00a0 while the macules of McCune-Albright are midline and have\u00a0a jagged\u00a0or irregular appearance.\u00a0 Additionally, neurofibromatosis characteristically presents with neurofibromas, which are lacking in McCune-Albright syndrome. [1]"}
{"id": "article-24799_18", "title": "McCune-Albright Syndrome -- Differential Diagnosis", "content": "Fibrous dysplasia is\u00a0common as an isolated finding\u00a0of single or multiple lesions.\u00a0 While some\u00a0lesions are\u00a0caused by the same GNAS mutation as McCune-Albright, in the absence of endocrinopathy and caf\u00e9-au-lait macules, the diagnosis of isolated fibrous dysplasia is more likely. [2]", "contents": "McCune-Albright Syndrome -- Differential Diagnosis. Fibrous dysplasia is\u00a0common as an isolated finding\u00a0of single or multiple lesions.\u00a0 While some\u00a0lesions are\u00a0caused by the same GNAS mutation as McCune-Albright, in the absence of endocrinopathy and caf\u00e9-au-lait macules, the diagnosis of isolated fibrous dysplasia is more likely. [2]"}
{"id": "article-24799_19", "title": "McCune-Albright Syndrome -- Differential Diagnosis", "content": "Precocious puberty may be central or peripheral and in females is often idiopathic. Hormonally active tumors and congenital adrenal hyperplasia are other diagnostic considerations in patients presenting with precocious puberty. Patients presenting with precocious puberty should undergo skeletal survey to rule out McCune-Albright syndrome. [6]", "contents": "McCune-Albright Syndrome -- Differential Diagnosis. Precocious puberty may be central or peripheral and in females is often idiopathic. Hormonally active tumors and congenital adrenal hyperplasia are other diagnostic considerations in patients presenting with precocious puberty. Patients presenting with precocious puberty should undergo skeletal survey to rule out McCune-Albright syndrome. [6]"}
{"id": "article-24799_20", "title": "McCune-Albright Syndrome -- Prognosis", "content": "Prognosis may be challenging to ascertain due to the\u00a0varying severity of the disease. Younger patients with\u00a0renal phosphate wasting and\u00a0polyostotic lesions have a higher risk of clinically relevant bone pain and fracture. [12] The primary treatment goal of precocious puberty is the preservation of potential adult height. Without intervention, growth plates\u00a0close prematurely resulting in short\u00a0stature. [9] While rare, there is potential for malignant transformation of fibrous dysplastic lesions. [3] There are also reports of increased breast cancer risk. [1]", "contents": "McCune-Albright Syndrome -- Prognosis. Prognosis may be challenging to ascertain due to the\u00a0varying severity of the disease. Younger patients with\u00a0renal phosphate wasting and\u00a0polyostotic lesions have a higher risk of clinically relevant bone pain and fracture. [12] The primary treatment goal of precocious puberty is the preservation of potential adult height. Without intervention, growth plates\u00a0close prematurely resulting in short\u00a0stature. [9] While rare, there is potential for malignant transformation of fibrous dysplastic lesions. [3] There are also reports of increased breast cancer risk. [1]"}
{"id": "article-24799_21", "title": "McCune-Albright Syndrome -- Complications", "content": "Possible complications include pain and fracture at sites of fibrous dysplastic lesions.\u00a0 Because of phosphate wasting, there is an increased risk of developing rickets. Decreased adult stature is the main complication of untreated precocious puberty. [6]", "contents": "McCune-Albright Syndrome -- Complications. Possible complications include pain and fracture at sites of fibrous dysplastic lesions.\u00a0 Because of phosphate wasting, there is an increased risk of developing rickets. Decreased adult stature is the main complication of untreated precocious puberty. [6]"}
{"id": "article-24799_22", "title": "McCune-Albright Syndrome -- Deterrence and Patient Education", "content": "Patients and parents should receive counseling that the cause of McCune-Albright syndrome a spontaneous mutation and is not vertically transmittable to offspring. [1] Due to the wide variety of endocrinopathies, patients should receive close follow up with measurement of bone maturity and hormone levels.", "contents": "McCune-Albright Syndrome -- Deterrence and Patient Education. Patients and parents should receive counseling that the cause of McCune-Albright syndrome a spontaneous mutation and is not vertically transmittable to offspring. [1] Due to the wide variety of endocrinopathies, patients should receive close follow up with measurement of bone maturity and hormone levels."}
{"id": "article-24799_23", "title": "McCune-Albright Syndrome -- Enhancing Healthcare Team Outcomes", "content": "Given the wide variety of manifestations, many key specialists may be involved in patient care, including but not limited to pediatric orthopedic surgery, pediatric endocrinology, and physical therapy. Personalized care coordination is vital between pediatricians and pediatric nursing who need to maintain a high index of suspicion in recognizing endocrinopathies and pathologic fractures in McCune-Albright syndrome.", "contents": "McCune-Albright Syndrome -- Enhancing Healthcare Team Outcomes. Given the wide variety of manifestations, many key specialists may be involved in patient care, including but not limited to pediatric orthopedic surgery, pediatric endocrinology, and physical therapy. Personalized care coordination is vital between pediatricians and pediatric nursing who need to maintain a high index of suspicion in recognizing endocrinopathies and pathologic fractures in McCune-Albright syndrome."}
{"id": "article-24799_24", "title": "McCune-Albright Syndrome -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "McCune-Albright Syndrome -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}